Genotoxicity test battery – An assessment of its utility in early drug development
Author:
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 868-869, 503388
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Development of peptide therapeutics: A nonclinical safety assessment perspectiveRegulatory Toxicology and Pharmacology, 2020
- Getting a molecule into the clinic: Nonclinical testing and starting dose considerationsRegulatory Toxicology and Pharmacology, 2017
- Genotoxicity assessment of peptide/protein-related biotherapeutics: points to consider before testingMutagenesis, 2016
- Analysis of published data for top concentration considerations in mammalian cell genotoxicity testingMutagenesis, 2010
- Safety evaluation to support first-in-man investigations II: Toxicology studiesRegulatory Toxicology and Pharmacology, 2008
- How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM WorkshopMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2007
- Transient hypothermia induces micronuclei in miceMutation Research - Genetic Toxicology and Environmental Mutagenesis, 1998